δ-Aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro
1999

Effects of δ-Aminolaevulinic Acid on Cancer Treatment

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): Gibson S L, Havens J J, Nguyen M L, Hilf R

Primary Institution: University of Rochester School of Medicine and Dentistry

Hypothesis

Does δ-aminolaevulinic acid affect the efficacy of photodynamic therapy in cancer treatment?

Conclusion

The study found that δ-aminolaevulinic acid reduces protoporphyrin IX levels and treatment efficacy due to inhibition of an important enzyme.

Supporting Evidence

  • δ-aminolaevulinic acid treatment led to a significant reduction in protoporphyrin IX levels.
  • Porphobilinogen deaminase activity decreased by 80% after irradiation.
  • There was little gain in efficacy from a second treatment within 24 hours.

Takeaway

This study shows that a substance used in cancer treatment can actually make the treatment less effective if used too soon after the first dose.

Methodology

The study involved culturing R3230AC rat mammary adenocarcinoma cells and measuring protoporphyrin IX levels and enzyme activity after treatment with δ-aminolaevulinic acid and irradiation.

Limitations

The study was conducted in vitro, which may not fully represent in vivo conditions.

Participant Demographics

R3230AC rat mammary adenocarcinoma cells

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690454

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication